Foley is pleased to sponsor the BIOCOM Medical Device Program, “Finding the Balance: Achieving Innovation, the FDA and Patient Safety.” Attend to learn how medical device companies balance the desire for innovative products against the FDA requirement of low risk products and assured patient safety. Hear from companies that have been successful in receiving FDA approvals and find out how companies achieve innovation and balance it against the regulations. Local companies will share what they have learned from their interaction with the FDA and what to expect in the future. Lastly, hear how an innovation-focused culture can be established while complying with structured FDA practices.
David Rosen, Partner & Co-Chair, Foley’s Life Sciences Industry Team
Kyle Armantrout, Director Molecular Marketing. Focus Diagnostics, Inc.
Zoran Psenicnik, Quality Engineering Manager, Respironics
For information and registration, please visit www.biocom.org.